Full-Time

Senior Scientist II

In Vivo Therapeutics Discovery

Updated on 5/17/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops CRISPR-based gene editing therapies

Biotechnology

Senior

Cambridge, MA, USA

Requirements
  • PhD in cell and molecular biology
  • 8-10 years of research experience
  • ≥5 years in an industry setting
Responsibilities
  • Serve as subject matter expert and lead early-stage discovery programs through DC nomination
  • Lead assay development and implementation to demonstrate gene editing and impact on target expression in relevant cells in vitro and target tissues in vivo
  • Plan and execute mouse experiments to understand in vivo therapeutic activity, efficacy, and PK/PD properties associated with drug candidates
  • Perform in vitro or ex vivo assays to assess disease phenotype
  • Contribute to the exploration and identification of new targets and engage with cross-functional stakeholders to determine the probability of technical, clinical, and commercial success
  • Contribute to timeline, milestones, success criteria, MPP, and TPP development
  • Generate technical documents, SOPs, study reports and other forms of documentation for IND-enabling activities and procedure development
  • Suggest and implement changes to IACUC protocols
  • Synthesize literature, analyze and present data within and outside the organization
  • Serve as a technical and scientific resource for junior staff
  • Share responsibility in maintaining lab equipment and reagent inventory
  • Maintain electronic lab notebook in a timely fashion
  • Interact with vendors, collaborators, and internal teams for various functions

Editas Medicine is a leader in the biotechnology industry, focused on developing cutting-edge CRISPR gene editing technologies to create transformative medicines for serious diseases. This focus places the company at the forefront of genetic research and therapy development, providing a dynamic and pioneering environment for its employees. As a workplace, it promises a culture of constant learning and innovation, ideal for those passionate about advancing healthcare and contributing to vital medical breakthroughs.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

15%

1 year growth

27%

2 year growth

18%